Currently holds a position at Onconova Therapeutics Inc
Position | Company | Period |
---|---|---|
Vice President, Corporate Development and General Counsel | Onconova Therapeutics Inc | Dec. 10, 2018 - |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2022-01-18 | 2022-01-14 |
Onconova Therapeutics Inc
(ONTX)
|
PP Planned purchase |
1,500
+7.5%
2.203,300 USD |
1,500 +7.5% | 2.20 | 3,300 USD | |
2022-01-10 | 2022-01-07 |
Onconova Therapeutics Inc
(ONTX)
|
PP Planned purchase |
1,500
+8.1%
2.393,585 USD |
1,500 +8.1% | 2.39 | 3,585 USD | |
2021-11-23 | 2021-11-19 |
Onconova Therapeutics Inc
(ONTX)
|
B Purchase |
1,000
+5.7%
3.163,160 USD |
1,000 +5.7% | 3.16 | 3,160 USD | |
2021-09-29 | 2021-09-28 |
Onconova Therapeutics Inc
(ONTX)
|
B Purchase |
2,381
+23.5%
4.2010,000 USD |
2,381 +23.5% | 4.20 | 10,000 USD | |
2021-02-17 | 2021-02-16 |
Onconova Therapeutics Inc
(ONTX)
|
B Purchase |
12,000
+8.6%
1.0012,000 USD |
12,000 +8.6% | 1.00 | 12,000 USD | |
2020-12-14 | 2020-12-11 |
Onconova Therapeutics Inc
(ONTX)
|
B Purchase |
30,000
+27.3%
0.329,600 USD |
30,000 +27.3% | 0.32 | 9,600 USD | |
2020-11-30 | 2020-11-25 |
Onconova Therapeutics Inc
(ONTX)
|
B Purchase |
20,000
+22.2%
0.265,120 USD |
20,000 +22.2% | 0.26 | 5,120 USD | |
2020-05-20 | 2020-05-19 |
Onconova Therapeutics Inc
(ONTX)
|
B Purchase |
15,000
+20.0%
0.375,550 USD |
15,000 +20.0% | 0.37 | 5,550 USD |